Volume 18, Issue 1, Pages (January 2016)

Slides:



Advertisements
Similar presentations
Volume 18, Issue 3, Pages (March 2016)
Advertisements

Neighborhood Level Effects of Socioeconomic Status on Liver Transplant Selection and Recipient Survival  R. Cutler Quillin, Gregory C. Wilson, Koffi Wima,
Volume 150, Issue 2, Pages e6 (February 2016)
Volume 18, Issue 9, Pages (September 2016)
Volume 19, Issue 11, Pages (November 2017)
MELD: the holy grail of organ allocation?
Clinical and Personality Profiles and Survival in Patients With COPD
Donor age still matters in liver transplantation
Multidisciplinary Management of Hepatocellular Carcinoma
From Fat to Inflammation
Volume 133, Issue 2, Pages (August 2007)
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Volume 145, Issue 3, Pages (September 2013)
Focus on hepatocellular carcinoma
Volume 147, Issue 1, Pages (July 2014)
Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection  Adam.
Volume 146, Issue 5, Pages e1 (May 2014)
Living donor liver transplantation: is the hype over?
Recent Advances in Liver Transplantation
Roberts Brown, Jean C. Emond  Gastroenterology 
Volume 151, Issue 3, Pages e2 (September 2016)
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study  Shahrukh Hashmi, MD MPH, Timucin.
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F
Leigh Ann White, Joseph Menzin, Jonathan R
Volume 68, Issue 1, Pages (January 2018)
Correction Journal of the American College of Surgeons
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease  Sahil Mittal, Hashem.
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Current and Future Trends in Liver Transplantation in Europe
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Treatment response after radioembolisation in patients with hepatocellular carcinoma— An evaluation with dual energy computed-tomography  Jens Altenbernd,
Michael Charlton  Clinical Gastroenterology and Hepatology 
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery  Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, Vinay Badhwar,
Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources  Christopher M. Walker,
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States  Ju Dong Yang, Joseph.
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Organ transplantation: historical perspective and current practice
Lei Yu, Dana A. Sloane, Chuanfa Guo, Charles D. Howell 
Lance L. Stein, MD, Marty T. Sellers, MD, MPH 
Volume 133, Issue 2, Pages (August 2007)
Volume 133, Issue 2, Pages (August 2007)
Deceased-Donor Split-Liver Transplantation in Adult Recipients: Is the Learning Curve Over?  Ryan P. Cauley, MD, MPH, Khashayar Vakili, MD, FACS, Nora.
Volume 134, Issue 1, Pages (January 2008)
Evolution of liver transplantation for hepatocellular carcinoma
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A
Volume 141, Issue 4, Pages (October 2011)
Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T
Volume 135, Issue 4, Pages (October 2008)
Liver Transplantation for Hepatocellular Carcinoma
Hematochezia From Metastasis of Hepatocellular Carcinoma to Colon in a Patient Who Underwent Liver Transplantation  Ruhail Kohli, Andrei S. Purysko, Binu.
Eldad S. Bialecki, Amobi M. Ezenekwe, Elizabeth M. Brunt, Brian T
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
The outcome of the initial assessment of hepatocellular carcinoma (HCC) by a multidisciplinary meeting (MDM) with respect to treatment categorised as resection,
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Volume 150, Issue 2, Pages (February 2016)
Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study  Jessica A. Davila, Hashem B. El–Serag  Clinical.
Genetics of hepatocellular carcinoma: The next generation
Surgical outcomes after cardiac surgery in liver transplant recipients
Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer  Edoardo Giannini, Federica Botta,
MELD: the holy grail of organ allocation?
Volume 135, Issue 5, Pages (November 2008)
Volume 156, Issue 4, Pages (March 2019)
Outcome in cirrhotic patients after elective surgical repair of infrarenal aortic aneurysm  Massimiliano M. Marrocco-Trischitta, MD, PhD, Andrea Kahlberg,
Outcomes in liver transplantation: Does sex matter?
Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006  Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.
Reversion of disease manifestations after HCV eradication
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Presentation transcript:

Volume 18, Issue 1, Pages 29-34 (January 2016) Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database  Valery Vilchez, Malay B. Shah, Michael F. Daily, Luis Pena, Ching-Wei D. Tzeng, Daniel Davenport, Peter J. Hosein, Roberto Gedaly, Erin Maynard  HPB  Volume 18, Issue 1, Pages 29-34 (January 2016) DOI: 10.1016/j.hpb.2015.10.001 Copyright © 2015 Terms and Conditions

Figure 1 Patients transplanted for primary liver malignancy in UNOS database since 1994 to 2013. Out of 4049 patients, 94, 3515 and 440 have been transplanted for HCC-CC, HCC and CC, respectively. Liver primary malignancy as an indication of liver transplantation has increased since 2002, when the MELD score was implemented. Only 5 patients with HCC-CC where transplanted before 2002 HPB 2016 18, 29-34DOI: (10.1016/j.hpb.2015.10.001) Copyright © 2015 Terms and Conditions

Figure 2 (a) Patient survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma. (b) Patient survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma vs. hepatocellular carcinoma and cholangiocarcinoma. (c) Graft survival after liver transplantation for mixed hepatocellular and cholangiocarcinoma vs. hepatocellular carcinoma and cholangiocarcinoma HPB 2016 18, 29-34DOI: (10.1016/j.hpb.2015.10.001) Copyright © 2015 Terms and Conditions